MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • Noticias
  • Store
  • Corredores
  • Descargar
  • Calendario económico
  • Señales Comerciales
  • WebTerminal
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
AN2 Therapeutics, Inc. Common Stock

ANTX

#3609
AN2 Therapeutics, Inc. Common Stock
1.10
+1.85%
Sector:
Básica:
Profit Currency:
Rango diario
1.10
1.10
Rango anual
1.00
1.55
Cambio diario
+1.85%
Monthly Change
-7.56%
6 month change
-3.51%
Cambio anual
+0.92%
Cierres anteriores
1.08
Open
1.10
Bid
Ask
Low
1.10
High
1.10
Volumen
1
  1. Markets
  2. Acciones
  3. Atención Sanitaria
  4. ANTX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Noticias

Investing Investing
ANTX
2026.01.29
AN2 Therapeutics nomina Sarah Williams come responsabile principale della contabilità
Investing Investing
ANTX
2026.01.29
AN2 Therapeutics appoints Sarah Williams as principal accounting officer
Investing Investing
ANTX
2026.01.12
FDA clears IND for epetraborole trial in mycobacterium abscessus
Zacks Zacks
ANTX
2026.01.09
AN2 Therapeutics (ANTX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Zacks
ALLO ANTX
2026.01.09
Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year?
Investing Investing
ANTX
2026.01.08
AN2 Therapeutics (ANTX): CFO Day vende azioni per $8883
Investing Investing
ANTX
2026.01.08
An2 therapeutics (ANTX): cfo Day sells $8883 in shares
Investing Investing
ANTX
2026.01.08
Il CSO di AN2 Therapeutics vende azioni per $6507
Investing Investing
ANTX
2026.01.08
An2 therapeutics CSO prior sells $6507 in stock
Investing Investing
ANTX
2026.01.08
Eizen, AN2 Therapeutics COO, sells $25k in ANTX stock
Investing Investing
ANTX
2026.01.08
An2 therapeutics chief development officer sells $9k in stock
Investing Investing
GSK ANTX
2025.11.10
AN2 Therapeutics collabora con GSK per sviluppare trattamenti contro la TB

Markets

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Charts & Ideas

  • Ideas comerciales
  • Ideas ilustrativas
  • Gráfico

MQL5 Community

  • Market
  • Señales
  • Foro
  • Artículos
  • CodeBase

Noticias

  • Acciones
  • Divisas
  • Criptomonedas
  • Metales
  • Mercancías

Corredores

  • Todos los brókeres
  • Fórex
  • Acciones
  • Metales
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Información y contacto Legal
Copyright 2000-2026, MetaQuotes Ltd